Eve Health Group (ASX:EVE) says it knows of no undisclosed information that would explain a sharp fall and surge in trading volume. The company suggested selling by a formerly associated shareholder may have contributed, without identifying the seller or quantifying the disposal.
- ASX flagged a fall from $0.015 to an intraday low of $0.009
- EVE denied awareness of undisclosed market-sensitive information
- Company cited possible selling by a formerly associated shareholder
- EVE confirmed compliance with continuous disclosure obligations
- No trading halt was requested in the response
ASX queries 40% intraday price decline
Eve Health Group Limited (ASX:EVE) has told the ASX it is unaware of any undisclosed information that could explain the company’s recent share-price and volume activity, after the exchange flagged a fall from a $0.015 close on 23 October to an intraday low of $0.009 on 26 October.
That move represented a decline of 40% from the earlier closing price, while ASX Supervision also noted a significant increase in the number of EVE securities traded over the same period. The exchange issued its price and volume query under Listing Rule 18.7 and required a response by 2.30pm AWST on Monday.
Company points to possible shareholder disposal
EVE’s explanation was that a shareholder formerly associated with the company may be disposing of their holding. The company said it considered this selling may have significantly contributed to the recent trading, but did not identify the shareholder, disclose the size of any disposal or present it as a definitive explanation.
That leaves the proposed cause unverified from the announcement itself. The company said it was not aware of any other explanation for the activity, while also making clear that it knew of no information being withheld from the market under the continuous disclosure exceptions.
EVE confirms Listing Rule compliance
EVE confirmed it was complying with the ASX Listing Rules, including Listing Rule 3.1, which covers the prompt disclosure of market-sensitive information. It also said the response had been authorised under its continuous disclosure policy.
The exchange’s letter warned that if undisclosed information had existed and could not be released immediately, EVE might have needed to seek a trading halt. ASX also said it could suspend trading if the company failed to respond by the required deadline. EVE’s response did not request a halt or indicate that one was being considered.
Trading records and holder notices become the next evidence
For shareholders, the key unresolved issue is whether the possible disposal produces a formal ownership disclosure or whether the unusual activity fades without further explanation. Subsequent substantial-holder notices, any additional ASX correspondence and changes in volume may help establish whether one seller was responsible for the move.
Bottom Line?
EVE has answered the ASX query without revealing a new corporate development, but the identity and scale of the possible shareholder disposal remain unresolved.
Questions in the middle?
- Will the formerly associated shareholder lodge a substantial-holder notice or otherwise clarify the suspected selling?
- Did the higher volume continue after EVE’s response, or was the activity concentrated around 26 October?
- Will ASX seek further information if the price or volume pattern remains unusual?